Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice

European Journal of Pharmacology

Volumn 276, Issue 1-2, 1995, Pages 131-135

  Kamei, Junzo ^a   Saitoh, Akiyoshi ^a   Ohsawa, Masahiro ^a   Suzuki, Tsutomu ^a   Misawa, Miwa ^a   Nagase, Hiroshi ^b   Kasuya, Yutaka ^a  

^a HOSHI UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

7 Benzylidenenaltrexone; Antinociception; Naltriben diabetes; TAN 67; Opioid receptor

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 7 BENZYLIDENEALTREXONE; ACETIC ACID; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALTRIBEN; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DELTA 1 OPIATE RECEPTOR; DELTA 2 OPIATE RECEPTOR; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; WRITHING TEST;

ANALGESICS; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; MALE; MICE; MICE, INBRED ICR; QUINOLINES; RECEPTORS, OPIOID, DELTA;

EID: 0028967685     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00026-H     Document Type: Article

References (18)

1. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86
2. Nor-binaltorphimine: a potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo
3. 6]enkephalin and naltrindole 5-isothiocyanate: evidence for delta receptor subtypes
4. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ-opioid receptors
5. Effects of diabetes on stress-induced analgesia in mice
6. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ-and κ-opioid agonists
7. Effect of diabetes on the antitussive effect of β-endorphin
8. 2-opioid receptors
9. 2-opioid receptors
10. A simplified method of evaluating dose-effect experiments
11. 2]deltorphin II in mice: evidence for delta receptor subtypes
12. Syntheses of non-peptidic delta opioid agonists and their structure activity relationships
13. Role of spacer and address components in peptidomimetic δ opioid receptor antagonists related to naltrindole
14. 1-opioid receptor antagonist: 7-benzylidenenaltrexone
15. Differential antagonism of delta opioid agonists by naltrindole (NTI) and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes
16. Crosstolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypes
17. Antinociceptive actions of BW373U86 in the mouse